
浏览全部资源
扫码关注微信
纸质出版:2016
移动端阅览
刘亮,肖堂利,余彦霖,何婷,徐新丽,管旭,杨可,张道海,郑昌玲,赵景宏.过氧化物酶体增殖物激活受体γ抑制高磷诱导血管平滑肌细胞钙化[J].陆军军医大学学报(原第三军医大学学报),2016,38(02):124-128.
Liu Liang,Xiao Tangli,Yu Yanlin,He Ting,Xu Xinli,Guan Xu,Yang Ke,Zhang Daohai,Zheng Changling,Zhao Jinghong.PPARγ inhibits calcification in vascular smooth muscle cells induced by high phosphate[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(02):124-128.
刘亮,肖堂利,余彦霖,何婷,徐新丽,管旭,杨可,张道海,郑昌玲,赵景宏.过氧化物酶体增殖物激活受体γ抑制高磷诱导血管平滑肌细胞钙化[J].陆军军医大学学报(原第三军医大学学报),2016,38(02):124-128. DOI:
Liu Liang,Xiao Tangli,Yu Yanlin,He Ting,Xu Xinli,Guan Xu,Yang Ke,Zhang Daohai,Zheng Changling,Zhao Jinghong.PPARγ inhibits calcification in vascular smooth muscle cells induced by high phosphate[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(02):124-128. DOI:
目的 探讨过氧化物酶体增殖物激活受体γ(peroxisome proliferators activated receptor γ
PPARγ)对高磷诱导的小鼠血管平滑肌细胞(vascular smooth muscle cells
VSMCs)钙化的抑制作用。 方法 体外培养小鼠血管平滑肌细胞,先分正常对照组、高磷组(HP,2.6 mmol/L),观察高磷对VSMCs的影响,再分为正常对照组、高磷组(HP
2.6 mmol/L)、罗格列酮组(RGL
10 μmol/L)、高磷 (2.6 mmol/L)+罗格列酮 (10 μmol/L)组(HP+RGL)
观察PPARγ激动剂罗格列酮对高磷诱导的VSMCs钙化的抑制作用。茜素红S(alizarin red S)染色观察高磷对细胞钙盐沉积的影响。Western blot检测PPARγ、血管平滑肌22alpha蛋白标志物 (SM22α)、骨形成蛋白2(BMP2)和成骨特异性转录因子2(Runx2)的表达变化。 结果 与正常对照组相比,高磷处理后的VSMCs的钙盐沉积明显升高[(0.08±0.02) vs (0.19±0.03),P0.01],成骨细胞标志物BMP2[(0.26±0.02) vs (0.74±0.03)
P0.01]及Runx2表达 [(0.29±0.03) vs (0.91±0.04)
P0.01)],明显升高。同时PPARγ[(0.93±0.04) vs (0.58±0.02)
P0.05]及平滑肌细胞标志物SM22α表达减少[(1.02±0.09) vs (0.77±0.03)
P0.05],而加入罗格列酮后,高磷状态下VSMCs的钙盐沉积明显降低[(0.19±0.02) vs (0.12±0.03)
P0.05],PPARγ[(0.63±0.04) vs (0.85±0.03)
P0.05]和SM22α[(0.69±0.02) vs (0.99±0.03)
P0.01]表达明显上升,相反,BMP2[(1.02±0.04) vs (0.48±0.05)
P0.01]及Runx2[(1.00±0.06) vs (0.67±0.03)
P0.01]的表达则明显受抑。 结论 高磷诱导VSMCs向成骨细胞分化和钙化可能与下调PPARγ的表达有关,而罗格列酮可通过激活PPARγ抑制高磷状态下VSMCs钙化的发生。
Objective To determine the role of peroxisome proliferators activated receptor γ (PPARγ) in calcification of vascular smooth muscle cells (VSMCs) induced by high phosphate. Methods Cultured mouse VSMCs were divided into normal phosphate (NP) group and high phosphate (HP
2.6 mmol/L) group
and the effect of HP on VSMCs was observed. Then the VSMCs were divided into NP group
HP (2.6 mmol/L) group
rosiglitazone (RGL
10 μmmol/L) group
and HP+RGL (2.6 mmol/L+10 μmmol/L) group
and the inhibitory effect of PPARγ agonist RGL on the calcification of VSMCs induced with HP was observed. Alizarin red S staining was used to observe HP-induced calcification of VSMCs. Expression level of PPARγ
SM22α
BMP2
and Runx2 were measured by Western blotting. Results Compared with the NP group
calcium salt deposition of HP-treated VSMCs was higher (0.08±0.02 vs 0.19±0.03
P0.01)
the expression levels of BMP2 (0.26±0.02 vs 0.74±0.03
P0.01) and Runx2 (0.29±0.03 vs 0.91±0.04
P0.01) were increased significantly
and the expression levels of PPARγ (0.93±0.04 vs 0.58±0.02
P0.05) and SM22α (1.02±0.09 vs 0.77±0.03
P0.05) were decreased significantly. After incubation with RGL
calcium salt deposition of HP-treated VSMCs was reduced (0.19±0.02 vs 0.12±0.03
P0.05)
the expression levels of PPARγ (0.63±0.04 vs 0.85±0.03
P0.05) and SM22α (0.69±0.02 vs 0.99±0.03
P0.01) were markedly elevated
and the expression levels of BMP
(1.02±0.04 vs 0.48±0.05
P0.01) and Runx2 (1.00±0.06 vs 0.67±0.03
P0.01) were dropped markedly. Conclusion HP-induced osteoblast differentiation and calcification of VSMCs may be related with the down-regulation of PPARγ
and HP-induced calcification of VSMCs can be inhibited by RGL.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621